These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12677701)

  • 1. [Evidence based conservative therapy of gastroesophageal reflux].
    Schilling D; Riemann JF
    Internist (Berl); 2003 Jan; 44(1):21-7. PubMed ID: 12677701
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?
    Freston JW
    Gut; 2001 Nov; 49(5):616-7. PubMed ID: 11600461
    [No Abstract]   [Full Text] [Related]  

  • 3. [Helicobacter pylori: changes of indications for eradication therapy].
    Koop H
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S91-3. PubMed ID: 15368180
    [No Abstract]   [Full Text] [Related]  

  • 4. Protagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?
    Labenz J
    Gut; 2001 Nov; 49(5):614-6. PubMed ID: 11600460
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of the treatment of duodenal ulcer associated with Helicobacter pylori and combined with gastroesophageal reflux disease].
    Vasil'ev IuV; Nikol'skaia KA
    Eksp Klin Gastroenterol; 2005; (6):61-4. PubMed ID: 17378390
    [No Abstract]   [Full Text] [Related]  

  • 6. Helicobacter pylori infection and long term proton pump inhibitor therapy.
    McColl KE
    Gut; 2004 Jan; 53(1):5-7. PubMed ID: 14684566
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastroesophageal reflux in the adult: what are the results of medical treatments? (II)].
    Zerbib F
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S255-73. PubMed ID: 10078456
    [No Abstract]   [Full Text] [Related]  

  • 8. Choosing one PPI treatment over another.
    Dachs R; Darby-Stewart A; Graber M
    Am Fam Physician; 2007 Nov; 76(9):1273-4. PubMed ID: 18019869
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Laine and Sugg-Helicobacter pylori eradication on esophagitis and GERD.
    Loffeld RJ
    Am J Gastroenterol; 2003 May; 98(5):1201-2; author reply 1202-3. PubMed ID: 12809850
    [No Abstract]   [Full Text] [Related]  

  • 10. [Helicobacter eradication in gastritis and ulcers. Causal therapy, prevention of stomach cancer].
    MMW Fortschr Med; 2003 Aug; 145(33-34):54-5. PubMed ID: 14526576
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmaco-economic evaluation ("cost-benefit" analysis) of gastroesophageal reflux treatment].
    Guseĭnzade MG; Li IA; Lazebnik LB
    Eksp Klin Gastroenterol; 2003; (5):40-4. PubMed ID: 14621609
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastroesophageal reflux disease (GERD). Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease].
    Mizuno M; Ishiki K; Take S
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():297-300. PubMed ID: 16363548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of gastroesophageal reflux: should Helicobacter pylori infection be taken into account?].
    De Korwin JD
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S121-9. PubMed ID: 10078440
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reflux after Helicobacter pylori eradication. What is the ambivalence about?].
    Czettritz T
    MMW Fortschr Med; 2000 Oct; 142(43):12. PubMed ID: 11098606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-ulcer agents: indications in adult patients. Recommendations for good practice. French Agency for the Sanitary Safety of Health Products].
    Gastroenterol Clin Biol; 2000 Apr; 24(4):447-60. PubMed ID: 10844290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 20. [Eradication euphoria is passé. Does H. pylori protect against reflux?. Interview by Dr. Brigitte Moreano].
    Riemann J
    MMW Fortschr Med; 2000 Sep; 142(38):8. PubMed ID: 11050882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.